Credit Suisse’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $9.57M | Buy |
|
|||||
|
2020
Q4 | $357K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $95K | Sell |
|
|||||
|
2019
Q2 | $195K | Buy |
|
|||||
|
2019
Q1 | $349K | Sell |
|
|||||
|
2018
Q4 | $258K | Buy |
|
|||||
|
2018
Q3 | $321K | Sell |
|
|||||
|
2018
Q2 | $658K | Sell |
|
|||||
|
2018
Q1 | $798K | Buy |
|
|||||
|
2017
Q4 | $786K | Sell |
|
|||||
|
2017
Q3 | $3.57M | Sell |
|
|||||
|
2017
Q2 | $2.69M | Sell |
|
|||||
|
2017
Q1 | $3.9M | Buy |
|
|||||
|
2016
Q4 | $3.81M | Sell |
|
|||||
|
2016
Q3 | $4.03M | Buy |
|
|||||
|
2016
Q2 | $2.66M | Buy |
|
|||||
|
2016
Q1 | $2.44M | Buy |
|
|||||
|
2015
Q4 | $371K | Sell |
|
|||||
|
2015
Q3 | $208K | Sell |
|
|||||
|
2015
Q2 | $1.46M | Buy |
|
|||||
|
2015
Q1 | $932K | Buy |
|
|||||
|
2014
Q4 | $514K | Buy |
|